This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

The Deal: Loblaw and Shoppers Drug Mart In $12B Merger

NEW YORK ( The Deal) -- Canadian grocery giant Loblaw Cos. Ltd said Monday it would acquire Shoppers Drug Mart Corp. in a C$12.4 billion ($11.9 billion) deal designed to fortify the company against increasing competition from U.S. rivals.

Terms of the deal call for Brampton, Ontario-based Loblaw to pay C$33.18 in cash and 0.5965 shares for total consideration of C$61.54 per share, a premium of 27% to the target's Friday close on the Toronto Stock Exchange. Shoppers stockholders will have the option to take cash or stock, with the maximum amount of cash to be paid by Loblaw capped at about C$6.7 billion.

Post-deal Shoppers holders would own about 29% of the combined company, which would generate about C$1 billion in annual free cash flow, C$3 billion in EBITDA and C$42 billion in annual sales. The companies said that combined they would be better able to compete against U.S. retail giants such as Target Corp. (TGT - Get Report) and Wal-Mart Stores Inc. (WMT - Get Report), which are increasingly encroaching upon Canadian territory.

Toronto-based Shoppers operates 1,242 retail drugstore locations under the Shoppers Drug Mart and Pharmaprix brands, and also licenses or owns 57 medical clinic pharmacies and owns 52 home healthcare stores. Loblaw already ranks as the largest food retailer in Canada, with more than 1,000 stores and 134,000 full and part-time employees.

The deal "changes the retail landscape in Canada," Loblaw CEO Galen G. Weston said in a statement, adding that the deal should "strengthen our position in the increasingly competitive marketplace." Shoppers would retain its brand and boost Loblaw's footprint in the small-urban store sector. "This combination creates a compelling new blueprint for the future, positioning us to capitalize on important trends in society, from the emphasis on health, wellness and nutrition, to the imperatives of value and convenience," Weston said. The deal comes just a week after a large U.S. grocery deal, Kroger Co.'s (KR - Get Report) $2.44 billion purchase of Harris Teeter Supermarkets Inc. (HTSI)

Loblaw said it would finance the deal with cash on hand and committed bank facilities including a C$3.5 billion term loan and C$1.6 billion bridge loan fully underwritten by BofA Merrill Lynch, Pierce, Fenner & Smith Inc., Bank of America NA, Canada branch and Bank of America NA (BAC). George Weston Ltd., Loblaw's controlling shareholder, has entered into a voting agreement to support the deal and will buy $500 million worth of common shares to help finance the purchase.

The company said it expects to shave C$300 million in annual costs within three years of closing, and said free cash flow should help it to quickly pay down its debts and maintain its current rating.

Bank of America Merrill Lynch, Torys LLP and Borden Ladner Gervais LLP are advising Loblaw. Shoppers Drug Mart received financial advice from RBC Capital Markets LLC and legal counsel from Osler, Hoskin & Harcourt LLP.

Written by Lou Whiteman

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
HTSI $0.00 0.00%
KR $69.65 -0.47%
TGT $77.72 -0.36%
WMT $82.58 -0.95%
AAPL $128.54 -0.63%

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs